搜索页_+FOLFOXIRI

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

外文资源

Elsevier电子期刊(22)

在“Elsevier电子期刊”中，命中：22条，耗时：小于0.01 秒

在所有数据库中总计命中：22条

1.Understanding the FOLFOXIRI-regimen to optimize treatment for metastatic colorectal cancer

作者：Yu Sunakawa^a ; ^b ; ¹ ; ^{y.suna0825@gmail.com" class="auth_mail" title="E-mail the corresponding author}Author Vitae ; Marta Schirripa^b ; ^c ; ¹Author Vitae ; Heinz-Josef Lenz^bAuthor Vitae

关键词：Metastatic colorectal cancer ; First-line ; FOLFOXIRI ; Bevacizumab ; Anti-EGFR

刊名：Critical Reviews in Oncology and Hematology

出版年：2016

2.FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

作者：Chiara Cremolini ; MD^a ; ^b ; ^&dagger ; ; Fotios Loupakis ; PhD^a ; ^b ; ^&dagger ; ; Carlotta Antoniotti ; MD^a ; ^b ; Cristiana Lupi ; BSc^c ; Elisa Sensi ; PhD^c ; Sara Lonardi ; MD^d ; Silvia Mezi ; MD^e ; Gianluca Tomasello ; MD^f ; Monica Ronzoni ; MD^g ; Alberto Zaniboni ; MD^h ; Prof Giuseppe Tonini ; MDⁱ ; Chiara Carlomagno ; PhD^j ; Giacomo Allegrini ; MD^k ; Silvana Chiara ; MD^l ; Mauro D'Amico ; MD^m ; Cristina Granetto ; MDⁿ ; Marina Cazzaniga ; MD^o ; Luca Boni ; MD^p ; Prof Gabriella Fontanini ; PhD^c ; Prof Alfredo Falcone ; MD^a ; ^b ; ^{alfredo.falcone@med.unipi.it" class="auth_mail" title="E-mail the corresponding author}

刊名：The Lancet Oncology

出版年：2015

3.First report of a Japanese phase I study of triplet plus bevacizumab for chemotherapy-naive metastatic colorectal cancer (J1-TRIBE study)

作者：Hironaga Satake ; ^{takeh1977@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Akihito Tsuji ^{akihito00tsuji@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Takeshi Kotake ^{t-kotake@kcho.jp" class="auth_mail" title="E-mail the corresponding author} ; Yoshihiro Okita ^{yokita@kcho.jp" class="auth_mail" title="E-mail the corresponding author} ; Yukimasa Hatachi ^{yukimasa@kcho.jp" class="auth_mail" title="E-mail the corresponding author}

关键词：FOLFOXIRI ; Bevacizumab ; Advanced colorectal cancer ; Phase I trial ; Triplet

刊名：Cancer Treatment Communications

出版年：2015

4.FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer

作者：F. Loupakis ; C. Cremolini ; L. Salvatore ; G. Masi ; E. Sensi ; M. Schirripa ; A. Michelucci ; E. Pfanner ; I. Brunetti ; C. Lupi ; C. Antoniotti ; F. Bergamo ; S. Lonardi ; V. Zagonel ; P. Simi ; G. Fontanini ; A. Falcone

关键词：Colorectal cancer ; BRAF ; Chemotherapy ; Bevacizumab ; FOLFOXIRI

刊名：European Journal of Cancer

出版年：January, 2014

5.2049 AIO-KRK-0109: A randomized phase II trial of panitumumab plus FOLFOXIRI or FOLFOXIRI alone as 1st-line treatment in RAS-wild-type metastatic colorectal cancer (mCRC)

作者：U.M. Martens ; S. Wessendorf ; J. Riera Knorrenschild ; P. Buechner-Steudel ; A. Florschuetz ; J. Atzpodien ; J. Greeve ; S. Kanzler ; T. Ettrich ; U. Lindig ; M. Egger ; H. Hebart ; M. Geissler

刊名：European Journal of Cancer

出版年：2015

6.2101 FOLFOXIRI versus FOLFOX/FOLFIRI plus Bevacizumab as first-line treatment in metastatic colorectal cancer: A systematic review and network Meta-analysis of phase III study

刊名：European Journal of Cancer

出版年：2015

7.Outcome of Second-Line Treatment After First-Line Chemotherapy With the GONO FOLFOXIRI Regimen

作者：Lorenzo Fornaro¹ ; Enrico Vasile¹ ; ^{envasile@tin.it} ; Gianluca Masi¹ ; Fotios Loupakis¹ ; Giacomo Giulio Baldi¹ ; Giacomo Allegrini² ; Lisa Salvatore¹ ; Chiara Cremolini¹ ; Samanta Cupini³ ; Enrico Cortesi⁴ ; Alessandro Tuzi⁴ ; Cristina Granetto⁵ ; Isa Maura Brunetti⁶ ; Sergio Ricci⁶ ; Alfredo Falcone¹ ; ⁷

关键词：5-Fluorouracil ; Chemotherapy ; Irinotecan ; Oxaliplatin ; Triplet regimen

刊名：Clinical Colorectal Cancer

出版年：2012

8.Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG)

作者：L. Vamvakas ; A. Athanasiadis ; A. Karampeazis ; S. Kakolyris ; A. Polyzos ; Ch. Kouroussis ; N. Ziras ; K. Kalbakis ; V. Georgoulias ; J. Souglakos

关键词：FOLFOXIRI ; FOLFIRI ; Elderly patients ; CRC ; Phase III study

刊名：Critical Reviews in Oncology/Hematology

出版年：2010

9.Multiorgan Failure in a Patient Treated With the 5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Regimen

作者：Andrew D. Schwartzman¹ ; ^{adschwar@bidmc.harvard.edu} ; Roshan Sethi¹ ; Roy Smith²

关键词：Adenocarcinoma of duodenum ; Multiorgan failure ; FOLFOXIRI

刊名：Clinical Colorectal Cancer

出版年：2013

10.Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial

作者：Gianluca Masi ; Fotios Loupakis ; Lisa Salvatore ; Lorenzo Fornaro ; Chiara Cremolini ; Samanta Cupini ; Andrea Ciarlo ; Francesca Del Monte ; Enrico Cortesi ; Domenico Amoroso ; Cristina Granetto ; Gabriella Fo

刊名：Lancet Oncology

出版年：2010

按检索点细分(22)

题名(16)

关键词(7)

文摘(10)

按出版年细分(22)

2027年及以后(1)

2016年(1)

2015年(4)

2013年(1)

2012年(2)

2010年(3)

2009年(5)

2008年(2)

2007年(1)

2005年(1)

2003年(1)